Harmaline
| Harmaline | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 214.26 g/mol [1] |
| Appearance | Orthorhombic bipyramidal prisms, tablets from methanol, rhombic octahedra from ethanol [1] |
| Melting point | 229-231 °C [1] |
| Solubility | Slightly soluble in water, alcohol, ether; quite soluble in hot alcohol, dilute acids [1] |
| Predicted LogP | 2.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H14N2O |
| IUPAC name | 7-methoxy-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole |
| SMILES | CC1=NCCC2=C1NC3=C2C=CC(=C3)OC |
| InChI | InChI=1S/C13H14N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-4,7,15H,5-6H2,1-2H3 |
| InChIKey | RERZNCLIYCABFS-UHFFFAOYSA-N |
| CAS number | 304-21-2 |
| UNII | CN58I4TOET |
| PubChem CID | 3564 |
| Pharmacokinetics[] | |
|---|---|
| Onset | Oral: 1–2 hours, Intravenous injection: Seconds |
| Elimination half-life | 2 hours |
| Duration of action | Oral: 5–8 hours, Intravenous injection: "Much shorter" (than oral) |
| Routes of administration | Oral, intravenous |
Harmaline (also known as Dihydroharmine, Harmidine, Armalin, 3,4-Dihydroharmine, O-Methylharmalol, Harmalol methyl ether, 3H-Pyrido[3,4-b]indole, 4,9-dihydro-7-methoxy-1-methyl-, 1-Methyl-7-methoxy-3,4-dihydro-β-carboline, 4,9-Dihydro-7-methoxy-1-methyl-3H-pyrido(3,4-b)indole or 3H-Pyrido(3,4-b)indole, 4,9-dihydro-7-methoxy-1-methyl-) is a substance of the β-carboline class.
It is a constituent of tobacco.
Chemistry
Stereochemistry []
Harmaline is achiral.
Druglikeness
Lipinski's rule of five
Harmaline matches Lipinski's rule of five.Reagents
There are currently 6 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | orange > brown | |
| Mecke | brown > dark green | |
| Mandelin | brown > black | |
| Simon's | no blue color change | |
| Ehrlich | yellow | |
| Hofmann | yellow |
Pharmacology
MeSH Classification
Mechanism of action []
Three psychological active principles from the seeds of Peganum harmala L., harmine, harmaline and harmalol, showed vasorelaxant activities in isolated rat thoracic aorta preparations precontracted by phenylephrine or KCl with rank order of relaxation potency of harmine > harmaline > harmalol. The vasorelaxant effects of harmine and harmaline (but not harmalol) were attenuated by endothelium removal or pretreatment with a nitric oxide (NO) synthase Nomega-nitro-L-arginine methyl ester. In cultured rat aortic endothelial cells, harmine and harmaline (but not harmalol) increased NO release, which was dependent on the presence of external Ca2+. In endothelium-denuded preparations, pretreatment of harmine, harmaline or harmalol (3-30 microM) inhibited phenylephrine-induced contractions in a non-competitive manner. Receptor binding assays indicated that all 3 compounds interacted with cardiac alpha1-adrenoceptors with comparable affinities (Ki value around 31 - 36 microM), but only harmine weakly interacted with the cardiac 1,4-dihydropyridine binding site of L-type Ca2+ channels (Ki value of 408 microM). Therefore, the present results suggested that the vasorelaxant effects of harmine and harmaline are attributed to their actions on the endothelial cells to release NO and on the vascular smooth muscles to inhibit the contractions induced by the activation of receptor-linked and voltage-dependent Ca2+ channels. The vasorelaxant effect of harmalol was not endothelium-dependent. [1]
Experience reports
Erowid
There are currently 11 experience reports involving harmaline on Erowid: []- "The Power and The Glory" by Netrunner
- "Brutal Nausea" by Scott
- "Nice to Meet You My Name Is Harmaline" by Bjlly
- "Bells Ringing Through the Nerves" by PsychonautRN
- "The Light Was Dim and I Was Careless" by William
- "Probably Overkill" by Shamanistic
- "Alien Doctor's Appointment" by raginpages
- "Yin and Yang is One" by yinyang
- "The Mind Of God" by The Centre
- "Bird Flying Into A Cave" by Reynaldo
- "Then a Sense That I Was Spinning" by Yogurt
- "Every Drug I've taken so far (AMA)" by Used-Philosopher-408 (26 upvotes)
- "[Mushrooms, MAOI, NOS] Meeting Aliens, Getting Possessed, and Talking to the Gnomes" by ethnob711 (21 upvotes)
- "Smoking changa in the Portopottie, drinking sass piss and boofing acid" by sporeson (8 upvotes)
- "Syrian Rue (peganum harmala) - first experience with harmaline/harmala alkaloids" by cogito_ergo_sum_one (3 upvotes)
Legal status []
- Australia: Harmaline is a Schedule 9.
- Canada: Harmaline is a Schedule III.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3564, Harmaline. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3564
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Harmaline. UNII: CN58I4TOET. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/CN58I4TOET
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 09:11:32 |
| drugspro | ok | 2026-11-20 09:11:28 |
| erowid | ok | 2026-11-20 09:11:30 |
| gsrs | ok | 2026-11-20 09:11:28 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0030310) | 2026-11-20 09:11:28 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 09:11:31 |
| pubchem | ok | 2026-11-20 09:11:28 |
| ok | 2026-11-20 09:11:28 | |
| sider | missing (not in SIDER) | 2026-11-20 09:11:28 |
| structure | ok | 2026-11-20 09:11:28 |
| wikipedia | ok | 2026-11-20 09:11:28 |